Approvals/CIMA-AEMPS/RISEDRONATO SEMANAL COMBIX 35 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

Approved

STANDARD

RISEDRONATO SEMANAL COMBIX 35 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

Laboratorios Combix S.L.U.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 9d8b3b0b8f8c9bfd
Drug Cima Aemps Name: RISEDRONATO SEMANAL COMBIX 35 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number: 87533
Holder Company Name: Laboratorios Combix S.L.U.
Marketing Company Name: Laboratorios Combix S.L.U.
Authorization Date: 2022-05-30
Dosage Form: COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose: 35 mg
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: Yes
Company Name: Laboratorios Combix S.L.U.

RISEDRONATO SODIO HEMIPENTAHIDRATO

40,16 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

May 30, 2022

Approval ID

9d8b3b0b8f8c9bfd

Type

Standard